GBP4 and non-small cell lung carcinoma: In addition, We found high GBP4 expression could be used to identify an inflamed TME and immuno-hot tumors in NSCLC, and GBP4 could be used to predict the therapeutic efficacy of various therapies in NSCLC patients.